Vivani Medical- Warrants (14/03/2024) Return on Equity

Vivani Medical- Warrants (14/03/2024) (VANIW) currently reports a ROE of -138.73%. That is below the Healthcare sector average of -75.84%. Use the charts on this page to explore Vivani Medical- Warrants (14/03/2024)'s ROE history and peer comparisons.

Vivani Medical- Warrants (14/03/2024)'s ROE of -138.73% is lower than the Healthcare sector average of -75.84%. That is roughly 82.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Vivani Medical- Warrants (14/03/2024)'s current -138.73% should be judged against Healthcare norms (sector average: -75.84%) and against VANIW's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -138.73%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Vivani Medical- Warrants (14/03/2024), and consider following VANIW for alerts when major investors trade the stock.

Vivani Medical- Warrants (14/03/2024) is classified in the Healthcare sector. On ROE, it currently shows -138.73% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VANIW with unrelated industries.